A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)
Clinical trial NCT06893081 · COMPLETED
Trial details
- NCT number
- NCT06893081
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2025-06-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.